Drawing for NORTHWAY BIOTECH

USPTO serial 79300592

NORTHWAY BIOTECH

Reviewed by CopyMark Law Group

Reg. 6854450Status 700Registered
Filing date
Status date
Registration date
Sep 27, 2022
Examiner
LIEBL, ALEXANDRA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NORTHWAY BIOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes; albuminous preparations for medical purposes, namely, albumin dietary supplements; chemical preparations for medical purposes, namely for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19ACTIVE
042Scientific and technological services, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of manufacture processes for biotechnology products; technological consultation in the field of development of manufacturing processes for biotechnology productsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 7, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jan 13, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB
Jan 13, 2023FIMPFINAL DISPOSITION PROCESSED
Dec 27, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 27, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 24, 2022TMBNTTAB RELEASE CASE TO TRADEMARKS
Aug 24, 2022OP.TOPPOSITION TERMINATED NO. 999999
Aug 24, 2022OP.DOPPOSITION DISMISSED NO. 999999
Jun 21, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 27, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 6, 2021RFNTREFUSAL PROCESSED BY IB
Nov 20, 2021OP.IOPPOSITION INSTITUTED NO. 999999
Nov 8, 2021OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Nov 6, 2021OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED
Nov 5, 2021OPPFOPPOSITION PAPERS RECEIVED AT TTAB
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 20, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2021XAECEXAMINER'S AMENDMENT ENTERED
Sep 20, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Sep 20, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 15, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 15, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 15, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 15, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 13, 2021RFNTREFUSAL PROCESSED BY IB
Mar 23, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2021RFRRREFUSAL PROCESSED BY MPU
Mar 20, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2021DOCKASSIGNED TO EXAMINER
Jan 2, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Dec 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance